Bukovinian Medical Herald · May 28, 2026

CHANGES IN THE GLUTATHIONE SYSTEM OF RATS OF DIFFERENT AGES DURING EXPERIMENTAL SCOPOLAMINE-INDUCED NEURODEGENERATE PROCESS: THERAPEUTIC POTENTIAL OF CARBACETAM

By Дрезналь ЄП, Кметь ТІ

Alzheimer's disease is the leading cause of dementia in the world and is characterized by a progressive course with the formation of profound cognitive impairments. One of the key pathogenetic mechanisms of neurodegeneration is oxidative stress. The glutathione system plays a central role in maintaining redox homeostasis.The aim of the work was to study age-related changes in the glutathione system in rats during an experimental scopolamine-induced neurodegenerative process, and to assess the therapeutic potential of carbacetam for correcting oxidative stress and antioxidant protection disorders in animals of different ages.Materials and methods. The experiment was conducted on sexually mature and old male white rats. The neurodegeneration model was reproduced by intraperitoneal administration of scopolamine (1 mg/kg) for 27 days. Correction of disorders was carried out with carbacetam (5 mg/kg) for 14 days. In the tissues of the hippocampus and kidneys, the level of reduced glutathione (G-SH), the content of sulfhydryl (SH) groups, the activity of glutathione peroxidase (GP), glutathione reductase (GR) and glucose-6-phosphate dehydrogenase (G-6-FDG) were determined, with subsequent statistical analysis of the results obtained.Results. It was established that the development of neurodegeneration is accompanied by depletion of the glutathione system. A decrease in the level of G-SH and SH groups was noted in the hippocampus and kidneys. GP activity was significantly reduced in both organs, which limited the neutralization of peroxides. At the same time, GR was suppressed in the hippocampus, while its compensatory increase was detected in the kidneys, which was more pronounced in sexually mature animals. G-6-FDG activity decreased with the most pronounced changes in hippocampal tissues, which confirms its high sensitivity to oxidative stress.The use of carbacetam contributed to the normalization of the antioxidant system. Under the influence of the drug, the level of G-SH and SH-groups increased, the activity of GP, GR and G-6-FDG increased, which indicates the restoration of the functional capacity of the glutathione chain. The results indicate that carbacetam can improve cellular energy supply by activating the pentose phosphate pathway.Conclusion. It was established that scopolamine-induced neurodegeneration causes systemic disorders of antioxidant protection with pronounced age- and organ-specific features. Carbacetam exhibits a pronounced neuro- and nephroprotective effect, restoring the glutathione system and reducing the manifestations of oxidative stress. The obtained data substantiate the prospects for further studies of carbacetam as a potential means of correcting neurodegenerative processes and age-related metabolic disorders.

doi.org/10.24061/2413-0737.30.2.118.2026.19Open accessInterventions

AgingResearch.News